Approaches to immune checkpoint inhibitor (ICI) maintenance therapy in metastatic urothelial cancer (mUC): A qualitative analysis of oncology providers in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback